• Home>
  • Stocks>
  • Strides Pharma Science Ltd Share Price
Strides Pharma Science Ltd share price logo

Strides Pharma Science Ltd Share Price

(STAR)

Small Cap

Healthcare Sector

₹653▲1.82%

as on 04:01PM, 17 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Strides Pharma Science Ltd Performance

  • Day's Low

    Day's High

    ₹646.2
    Day's Price Range
    ₹666.95

  • 52 Week's Low

    52 Week's High

    ₹513.05
    52-Week Price Range
    ₹1,675
1 Month Return+ 3.08 %
3 Month Return+ 6.92 %
1 Year Return-22.71 %
Previous Close₹665.10
Open₹660.00
Volume2.89L
Upper Circuit₹798.10
Lower Circuit₹532.10
Market Cap₹6,018.23Cr

Strides Pharma Science Ltd Fundamentals

P/E Ratio

37.97

PEG Ratio

1.73

Market Cap

₹6,018.23 Cr

P/B Ratio

2.02

EPS

-4.49599698514042

Dividend Yield

0.32

Sector

Pharmaceuticals

ROE

1.87

Strides Pharma Science Ltd Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1472

Source: S&P Global Market Intelligence

Strides Pharma Science Ltd Share analysis

Strides Pharma Science Ltd price forecast by 2 analysts

Upside of125.42%

High

₹1874

Target

₹1472.00

Low

₹1070

Strides Pharma Science Ltd target price ₹1472, a slight upside of 125.42% compared to current price of ₹653. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Key events for Strides Pharma Science Ltd

  • Strides Pharma Launches New Subsidiary for Innovation - 11 Apr, 2025

    Strides Pharma Science Limited has incorporated a new wholly owned subsidiary, Pivot Path, to enhance life sciences and digital innovation. This entity will focus on outsourcing and business support services in the pharmaceutical sector, aligning with a previously announced Scheme of Arrangement. The incorporation aims to leverage advanced technologies and domain expertise, although operations have yet to commence.

  • Strides Pharma Recalls Testosterone Gel Over Safety Concerns - 04 Apr, 2025

    Strides Pharma has voluntarily recalled over 440,000 cartons of Testosterone Gel in the US after detecting benzene, a carcinogenic substance, raising significant health concerns.

  • Strides Pharma Expands with Acquisition in Singapore - 20 Mar, 2025

    Strides Pharma Science Limited has acquired Amexel Pte. Ltd. in Singapore, enhancing its global footprint and capabilities. The company aims for a 12-15% revenue increase in FY25, driven by its robust product pipeline and strategic growth initiatives. Currently trading at Rs 654, the stock has seen an 80% rise over the past year and multibagger returns of over 300% in three years.

  • Strides Pharma Announces Demerger from Arco Labs - 19 Mar, 2025

    Strides Pharma Science Limited has received in-principle approval for a demerger from Arco Labs, establishing a new subsidiary focused on Life Sciences. Additionally, the company has dissolved its non-operating subsidiary, Generic Partners UK.

  • Strides Pharma Gains from Singapore Acquisition - 17 Mar, 2025

    Strides Pharma's share price rose by 3% following its Singapore subsidiary's acquisition of a 100% stake in Amexel Pte. The acquisition aims to enhance collaborations and business engagements in the pharmaceutical sector across India, China, and Southeast Asia.

  • Strides Pharma Acquires Amexel for Strategic Growth - 15 Mar, 2025

    Strides Pharma Science announces the acquisition of Singapore-based Amexel for USD 10. This acquisition aims to enhance collaborations and procurement in the pharmaceutical sector across India and Southeast Asia.

Insights on Strides Pharma Science Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 25.84% to 26.82% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 18.18 Cr → 87.95 Cr (in ₹), with an average increase of 31.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.83% to 27.77% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.80% to 10.86% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 52.1% return, outperforming this stock by 74.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.1% return, outperforming this stock by 44.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, STAR stock has moved down by -59.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 30.08% to 28.48% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.19K Cr → 1.16K Cr (in ₹), with an average decrease of 2.9% per quarter

Strides Pharma Science Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,005.77Cr (-)₹1,084.04Cr (↑7.78%)₹1,087.51Cr (↑0.32%)₹1,166.93Cr (↑7.30%)₹1,153.67Cr (↓1.14%)
Net Income₹54.06Cr (-)₹10.44Cr (↓80.69%)₹68.31Cr (↑554.31%)₹72.27Cr (↑5.80%)₹90.04Cr (↑24.59%)
Net Profit Margin5.37% (-)0.96% (↓82.12%)6.28% (↑554.17%)6.19% (↓1.43%)7.80% (↑26.01%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,264.26Cr (-)₹5,478.46Cr (↑4.07%)₹5,658.16Cr (↑3.28%)₹5,871.07Cr (↑3.76%)
Total Liabilities₹2,016.20Cr (-)₹2,071.77Cr (↑2.76%)₹2,203.11Cr (↑6.34%)₹2,309.95Cr (↑4.85%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹137.64Cr (-)₹282.76Cr (↑105.43%)-₹282.69Cr (↓199.98%)₹241.74Cr (↓185.51%)-₹35.76Cr (↓114.79%)

Strides Pharma Science Ltd Index Inclusions

BSE Healthcare

₹41,697.12

0.91 (▲377.9%)

BSE Small-Cap

₹47,946.66

0.52 (▲248.31%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Strides Pharma Science Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
26.82%
3.81
Foreign Institutions
28.48%
-5.31
Mutual Funds
10.86%
0.57
Retail Investors
27.77%
7.48
Others
6.07%
-18.55

Strides Pharma Science Ltd Key Indicators

Details20202021202220232024
Return On Equity %3.752.445.290.611.87
Details20202021202220232024
Return On Assets %0.775.1-8.4-3.58-1.2
Details20202021202220232024
Book Value Per Share (₹)123.65135.68115.12106.52101.35
Details20202021202220232024
Earning Per Share (₹)1.512.59-23.15-10.3-4.5

Strides Pharma Science Ltd Valuation

Strides Pharma Science Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-409.06x)

July 5, 2021

Today (37.97x)

April 17, 2025

Industry (53.02x)

April 17, 2025

Highest (6306.63x)

September 27, 2024

LowHigh

Strides Pharma Science Ltd Earnings and Dividends

  • Strides Pharma Science Ltd Earnings Results

    Strides Pharma Science Ltd’s net profit jumped 77.07% since last year same period to ₹87.95Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 22.42% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Strides Pharma Science Ltd Dividends May,2024

    In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.61%.

    Read More about Dividends

Strides Pharma Science Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Strides Pharma Science Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Strides Pharma Science Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Strides Pharma Science Ltd
Strides Pharma Science Ltd
BUY₹6,018.23 Cr18.49%0.66-₹95 Cr₹4,051 Cr
Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd
NA₹123.14 Cr82.12%0.50NANA
Makers Laboratories Ltd
Makers Laboratories Ltd
NA₹87.21 Cr49.47%0.62-₹5 Cr₹104 Cr
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd
NA₹158.95 Cr5.86%0.60NANA
Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Ltd
NA₹23.89 Cr119.32%0.50NANA
See all

About Strides Pharma Science Ltd

Strides Pharma Science Ltd is an integrated pharmaceutical company listed on the Indian stock exchange. They are focused on developing, manufacturing and marketing pharmaceutical products in India and overseas. With a strong presence in regulated and semi-regulated markets, they offer a wide array of products ranging from Tablets, Capsules, Powders and Oral Liquids to Ointments, Softgel Capsules and Injectables. Their portfolio of services includes Product Development, Contract Manufacturing, Regulatory and Quality Compliance Support and Supply Chain Solutions. Their commitment to quality and innovation, along with the ability to serve their clients with a reliable, cost-effective and timely product supply, has helped them gain a foothold in the pharmaceutical industry. With their focus on meeting the ever-changing needs of customers, Strides Pharma Science Ltd is uniquely positioned in the pharmaceutical landscape.

Revenue: ₹1,153.67Cr as on December 2024 (Q4 24)
Net Profit: ₹90.04Cr as on December 2024 (Q4 24)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
OrganisationStrides Pharma Science Ltd
HeadquartersBangaluru
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Strides Pharma Science Ltd

What is Strides Pharma Science Ltd price today?

Strides Pharma Science Ltd share price today stands at ₹653, Open: ₹660, Previous Close: ₹665.1, High: ₹666.95, Low: ₹646.2, 52 Week High: ₹1675, 52 Week Low: ₹513.05.

How to Buy Strides Pharma Science Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Strides Pharma Science Ltd shares

What are today's traded volumes of Strides Pharma Science Ltd?

Today's traded volume of Strides Pharma Science Ltd(STAR) is 2.89L.

What is today's market capitalisation of Strides Pharma Science Ltd?

Today's market capitalisation of Strides Pharma Science Ltd(STAR) is ₹6018.23Cr.

What is the 52 Week High and Low Range of Strides Pharma Science Ltd?

Strides Pharma Science Ltd (STAR)
Price
52 Week High
₹1675
52 Week Low
₹513.05

How much percentage Strides Pharma Science Ltd is down from its 52 Week High?

Strides Pharma Science Ltd (STAR) share price is ₹653. It is down -61.01% from its 52 Week High price of ₹1675

How much percentage Strides Pharma Science Ltd is up from its 52 Week low?

Strides Pharma Science Ltd (STAR) share price is ₹653. It is up 27.28% from its 52 Week Low price of ₹513.05